Pharmaceutical

AbCellera and Regeneron expand antibody discovery collaboration

AbCellera and Regeneron have extended their current multi-target collaboration to discover therapeutic antibodies for up to eight targets

Sep 21, 2023 - 20:00
AbCellera and Regeneron expand antibody discovery collaboration
AbCellera and Regeneron have extended their current multi-target collaboration to discover therapeutic antibodies for up to eight targets
Read the original article

Tags:

Previous Article

EC grants approval for Menarini’s breast cancer therapy

Next Article

UCB’s Psoriasis Drug Application Faces a Further FDA Delay

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: When should hospitals require masks?

Opinion: When should hospitals require masks?

Jun 6, 2023

STAT+: Pharmalittle: AbbVie buys Immunogen, maker of targeted cancer drugs; Novo sues two more compounders

STAT+: Pharmalittle: AbbVie buys Immunogen, maker of ta...

Dec 1, 2023

Listen: Legal insider trading, booming biotech stocks, & the next GLP-1

Listen: Legal insider trading, booming biotech stocks, ...

Feb 29, 2024